Adempas 2 mg, film-coated tablets

( ARTG ) Pulmonary arterial hypertension:,Adempas, as monotherapy or in combination with approved PAH treatments (endothelin receptor antagonists or inhaled or subcutaneous prostanoids), is indicated for the treatment of:, idiopathic pulmonary arterial hypertension, he​​​‍​​‍​​​​‍​​‍‍ritable pulmonary arterial hypertension, pulmonary arterial hypertension associated with connective tissue diseases or, pulmonary arterial hypertension associated with congenital heart disease in adult patients with WHO functional Class II, lll or IV symptoms,Chronic thromboembolic pulmonary hypertension:,Adempas is indicated for the treatment of:,Persistent or recurrent chronic thromboembolic pulmonary hypertension (CTEPH) after surgical treatment or,inoperable CTEPH in adult patients with WHO functional Class II, lll or IV symptoms